parikalcitol medice 2 mikrograma/ml raztopina za injiciranje
medice arzneimittel pütter gmbh & co. kg - parikalcitol - raztopina za injiciranje - parikalcitol 2 µg / 1 viala - parikalcitol
parikalcitol medice 5 mikrogramov/ml raztopina za injiciranje
medice arzneimittel pütter gmbh & co. kg - parikalcitol - raztopina za injiciranje - parikalcitol 5 µg / 1 viala - parikalcitol
parikalcitol medice 5 mikrogramov/ml raztopina za injiciranje
medice arzneimittel pütter gmbh & co. kg - parikalcitol - raztopina za injiciranje - parikalcitol 5 µg / 1 viala - parikalcitol
parikalcitol medice 2 mikrograma/ml raztopina za injiciranje
medice arzneimittel pütter gmbh & co. kg - parikalcitol - raztopina za injiciranje - parikalcitol 2 µg / 1 viala - parikalcitol
parikalcitol medice 2 mikrograma/ml raztopina za injiciranje
medice arzneimittel pütter gmbh & co. kg - parikalcitol - raztopina za injiciranje - parikalcitol 2 µg / 1 viala - parikalcitol
parikalcitol medice 5 mikrogramov/ml raztopina za injiciranje
medice arzneimittel pütter gmbh & co. kg - parikalcitol - raztopina za injiciranje - parikalcitol 5 µg / 1 viala - parikalcitol
parikalcitol medice 5 mikrogramov/ml raztopina za injiciranje
medice arzneimittel pütter gmbh & co. kg - parikalcitol - raztopina za injiciranje - parikalcitol 5 µg / 1 viala - parikalcitol
parikalcitol medice 5 mikrogramov/ml raztopina za injiciranje
medice arzneimittel pütter gmbh & co. kg - parikalcitol - raztopina za injiciranje - parikalcitol 5 µg / 1 viala - parikalcitol
sevelamer heaton 800 mg filmsko obložene tablete
heaton k.s. - sevelamer - filmsko obložena tableta - sevelamer 800 mg / 1 tableta - sevelamer
cabometyx
ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - antineoplastična sredstva - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.